Wenham RM, Ray-Coquard I, Kristeleit R, Matei D, et al. Farletuzumab ecteribulin, a folate receptor alpha (FRalpha) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study. Gynecol Oncol 2026;213:109-119.
PMID: 42833056